Recently, the PD-1 receptor, originally identified on T cells, has been described on a subset NK cells as an additional inhibitory receptor that can block NK cell function against tumor cells expressing the specific ligands PD-L1 and PD-L2. Here, CD274 is linked to neoplasm.